A2LA is excited to welcome a new group of students to our summer 2021 internship program. Since 2012, A2LA has been welcoming interns to help young people gain real-life work experience in their chosen field, adding new programs and support tools each year. This year’s program kicks off in May, and over the next several weeks A2LA staff will get to meet and mentor seven young professionals in various departments. Each have kindly shared a little bit of information about themselves.
May 6, 2021- Frederick, MD – A2LA is pleased to announce the accreditation of Analabs, Inc. to ISO/IEC 17025:2017 for cannabis testing. Analabs, located in Crab Orchard, West Virginia, is the first cannabis testing laboratory to be accredited in the state.
A2LA has granted ISO/IEC 17065 accreditation to Americans for Safe Access (ASA), marking A2LA’s first-ever certificate of accreditation issued to a product certification body in the cannabis industry. ASA is an organization focused on ensuring safe, legal access to cannabis for therapeutic use and research. To that end, ASA has developed the “Patient Focused Certification” scheme to identify reliable, high-quality medical cannabis, businesses, products, and services.
Although industry conferences are looking very different these days, A2LA has continued to find ways to connect with customers and share information with others in the accreditation industry. For Pittcon 2021, in addition to a virtual booth, A2LA experts will be presenting four different informational sessions throughout the conference. We have identified topics of interest among our customers throughout the last several months and are eager to provide helpful insider perspectives. If you will be virtually attending Pittcon March 8-12th, please join us at any of the following four sessions, or visit our virtual booth for a one-on-one conversation our accreditation professionals.
Effective March 1st, 2021 the Oregon Health Authority has completed “Phase 3 Rulemaking” of the Toxic-Free Kids Act, a law requiring manufacturers of children’s products sold on Oregon to report and ultimately remove certain high priority chemicals of concern for children’s health (HPCCCH). This law is intended to reduce children’s exposure to chemicals of concern and improve scientific understanding of how children may be exposed to such chemicals.
A2LA is pleased to announce the accreditation of Cannalytics, LLC to ISO/IEC 17025:2017 for cannabis testing. Cannalytics, based in San Juan, Puerto, was accredited by A2LA in December 2020 and is the first cannabis testing laboratory accredited in Puerto Rico. Cannalytics is led by professionals with extensive laboratory experience in related fields, giving them the skills required to excel in cannabis testing. Owner and Director Jorge H. Diaz, MT (ASCP) and his team pursued accreditation with A2LA to establish themselves as quality leaders in the fast-expanding cannabis industry and to support a safe and consistent medical cannabis supply in Puerto Rico.
A2LA members have elected and approved two new individuals to A2LA’s Board of Directors for terms beginning January 1, 2021. Mike Carter, CEO of Western Energy Support and Technology (WEST), is an accomplished executive with over 29 years of experience in flow measurement and calibration. William Troy, a retired three-star Lieutenant General in the U.S. Army, is former CEO of the American Society for Quality, where he led a $40 million budget for the global, 68,000-member non-profit organization. The Board of Directors has also appointed Robin Stombler, President of Auburn Health Strategies, as its new Vice Chair.
Across every industry and every profession, 2020 has been a year of seismic change and challenging paradigm shifts. Yet amidst the stress of this pandemic there have also been opportunities for problem-solving, innovation, and collaboration. A2LA has needed to dramatically re-imagine the assessment process without sacrificing precision or integrity, which has only been possible because of the close, communicative relationships we maintain with our accredited organizations. Feedback from our customers has helped us develop an effective remote assessment process, which has in turn allowed our customers to keep their accreditation schedules on track and continue operating. This has been a dynamic undertaking, with our customers showing us how to best help them at every turn, and A2LA assessors and accreditation officers have continuously used customer input to shape their responses.
In a sweeping show of popular support, New Jersey, Arizona, Montana, and South Dakota have all voted to legalize the recreational use of marijuana, and Mississippi has voted to legalize marijuana for medical use. In all five states, the decision was made by ballot measure. These five states are only the latest in a massive and relatively rapid nationwide shift in support of marijuana access, leaving Idaho as the only state in the US where no form of cannabis (hemp or marijuana) is legal for any application. These ballot measures are expected to have a significant impact on the cannabis industry in the states where they passed, and to influence cannabis legislation in neighboring states.
A2LA has been granted ASCA (Accreditation Scheme for Conformity Assessment) Recognition by the FDA, making it among the first accreditation bodies accepted as a participant in the ASCA Pilot program. The ASCA Pilot is a cooperative program that relies on participation from accreditation bodies, testing laboratories, medical device manufacturers and FDA staff. Accreditation bodies like A2LA that meet the FDA’s requirements for this new program are granted ASCA Recognition, enabling them to assess testing laboratories seeking ASCA accreditation to perform premarket testing for medical device companies.